<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0003674'>Oxidative stress</z:mp> is one of the major pathological factors in the cascade that leads to cell <z:hpo ids='HP_0011420'>death</z:hpo> in <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Here, we investigated the neuroprotective effect of a naturally occurring <z:chebi fb="11" ids="22586">antioxidant</z:chebi>, oxyresveratrol, to reduce brain injury after cerebral <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>We used the transient rat middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) model of <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> to induce a defined <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Oxyresveratrol was given twice intraperitoneally: immediately after occlusion and at the time of reperfusion </plain></SENT>
<SENT sid="4" pm="."><plain>Oxyresveratrol (10 or 20 mg/kg) significantly reduced the brain <z:mpath ids='MPATH_124'>infarct</z:mpath> volume by approximately 54% and 63%, respectively, when compared to vehicle-treated MCAO rats </plain></SENT>
<SENT sid="5" pm="."><plain>Also, the neurological deficits as assessed by different scoring methods improved in oxyresveratrol-treated MCAO rats </plain></SENT>
<SENT sid="6" pm="."><plain>Histological analysis of apoptotic markers in the ischemic brain area revealed that oxyresveratrol treatment diminished <z:chebi fb="1" ids="18070">cytochrome c</z:chebi> release and decreased caspase-3 activation in MCAO rats </plain></SENT>
<SENT sid="7" pm="."><plain>Also, staining for apoptotic DNA showed that the number of apoptotic nuclei in ischemic brain was reduced after oxyresveratrol treatment as compared to the vehicle-treated MCAO rats </plain></SENT>
<SENT sid="8" pm="."><plain>This dose-dependent neuroprotective effect of oxyresveratrol in an in vivo <z:hpo ids='HP_0001297'>stroke</z:hpo> model demonstrates that this drug may prove to be beneficial for a therapeutic strategy to limit brain injury in <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> </plain></SENT>
</text></document>